A comprehensive analysis of more than 100,000 colorectal cancer (CRC) cases, led by researchers at the Fred Hutchinson Cancer Center in Seattle and 200 scientific collaborators worldwide, has identified more than 100 new ...
Dec 20, 2022
0
58
Uganda on Thursday received its first shipment of trial vaccines against a strain of Ebola that has claimed dozens of lives, amid cautious optimism the outbreak could soon be over.
Dec 8, 2022
0
6
In 2021, a group of scientists led by researchers at the University of North Carolina at Chapel Hill, Weill Cornell Medicine and NewYork-Presbyterian reported that the Moderna mRNA vaccine and a protein-based vaccine candidate ...
Dec 1, 2022
0
31
For decades, researchers have been working on "male birth control"—and studies show there is a demand. While concerns about side effects and efficacy have kept such options from the marketplace, efforts are moving forward, ...
Nov 30, 2022
0
0
Moderna announced Monday that its updated booster shot triggers strong antibody responses against three omicron subvariants.
Nov 15, 2022
0
4
After Alzheimer's, Parkinson's is the most common neurodegenerative disease in the world. More than six million people worldwide suffer from it. In this disease, alpha-synuclein proteins form thread-like structures called ...
Nov 15, 2022
0
980
A team of international scientists from Griffith University and the University of Alberta are about to start human clinical trials for a strep A vaccine they hope will induce long-lasting immunity against the deadly pathogen ...
Nov 10, 2022
0
2
Uganda on Saturday extended a three-week lockdown on two districts at the center of an Ebola outbreak which has claimed over 50 lives, curbing travel and closing public places.
Nov 6, 2022
0
51
Pfizer-BioNTech said Thursday they will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better inoculation uptake for both illnesses.
Nov 3, 2022
0
23
In laboratory and primate tests, a new pan-coronavirus vaccine developed by the Duke Human Vaccine Institute (DHVI) has demonstrated wide protection against SARS-CoV-2 viruses and variants, including omicron BA.5.
Oct 28, 2022
0
128
